4-6923449-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020773.3(TBC1D14):āc.60T>Gā(p.Asp20Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020773.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBC1D14 | NM_020773.3 | c.60T>G | p.Asp20Glu | missense_variant | 2/14 | ENST00000409757.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBC1D14 | ENST00000409757.9 | c.60T>G | p.Asp20Glu | missense_variant | 2/14 | 1 | NM_020773.3 | ||
TBC1D14 | ENST00000448507.5 | c.60T>G | p.Asp20Glu | missense_variant | 2/14 | 5 | |||
TBC1D14 | ENST00000444368.1 | c.60T>G | p.Asp20Glu | missense_variant | 2/2 | 3 | |||
TBC1D14 | ENST00000427736.1 | c.60T>G | p.Asp20Glu | missense_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152212Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727232
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.60T>G (p.D20E) alteration is located in exon 2 (coding exon 1) of the TBC1D14 gene. This alteration results from a T to G substitution at nucleotide position 60, causing the aspartic acid (D) at amino acid position 20 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at